| Tumor type | Exosome content | Exosome origin | Effector cells | Effector components |
| Melanoma | miR-Rab27a | Tumor | CD4+ T cells | BCL-2, BCL-xL | LC, breast cancer | / | Tumor | CD4+IFN-γ+ Th1 cells, DCs | / | HNC | / | Tumor | CD8+ T cells | CD27/CD28, IFN-γ | EOC | miR-29a-3p, miR-21-5p | Macrophage | Treg/Th17 cells | STAT3 signaling, Treg/Th17 ratios | HCC | HMGB1 | Tumor | T cells, TIM-1+ Breg cells, CD8+ T cells | TLR/MAPK pathway, IL-10 | Leukemia | lncRNA HOTAIR | Tumor | T lymphocytes, CD4+/CD8+ T cells | Wnt/β-catenin axis, Ig | CRC | miR-21-5p, miR-155-5p | Macrophage | Tumor cells | BRG1 | PC | / | Tumor | Macrophages | IL-6, IL-1β, and TNF-α | OC | / | Tumor | Monocytes | NF-κB pathway, IL-6, MMP9 | HCC | lncRNA TUC339 | Tumor | Macrophages | Costimulatory molecules | CC | miR-1246 | Tumor | Macrophages | TGF-β | GC | / | Tumor | Neutrophils | HMGB1/TLR4/NF-κB | PC | / | Tumor | Monocytes | STAT3 signaling, arginase, ROS | Leukemia | / | Tumor | Macrophages, BM-MSCs | TNF-α, IL-10, ROS | EC | Ecrg-4 mRNA | Tumor | / | Inflammation-related genes | Breast cancer | / | Camel milk | Tumor cells, CD 4+ T cells, CD8+ T cells | Tumor cell apoptosis, ROS | Glioma | miR-10a, miR-21 | Tumor | MDSCs | ROS, IL-10, TGF-β | LC | KIT | Mast cell | Tumor cells | KIT/SCF pathway |
|
|